Cargando…
Suppression of AKT Anti-Apoptotic Signaling by a Novel Drug Candidate Results in Growth Arrest and Apoptosis of Hepatocellular Carcinoma Cells
Hepatocellular carcinoma (HCC) is the third most common cause of cancer fatalities worldwide, with limited treatment options and five year survival rates of between <5 and 15%. To address this medical need, we conducted a screen of a drug-like small molecule library for HCC-selective cytotoxins....
Autores principales: | Cuconati, Andrea, Mills, Courtney, Goddard, Cally, Zhang, Xianchao, Yu, Wenquan, Guo, Haitao, Xu, Xiaodong, Block, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552860/ https://www.ncbi.nlm.nih.gov/pubmed/23355882 http://dx.doi.org/10.1371/journal.pone.0054595 |
Ejemplares similares
-
ARV-771 Acts as an Inducer of Cell Cycle Arrest and Apoptosis to Suppress Hepatocellular Carcinoma Progression
por: Deng, Yuanfei, et al.
Publicado: (2022) -
Synthetic Tryptanthrin Derivatives Induce Cell Cycle Arrest and Apoptosis via Akt and MAPKs in Human Hepatocellular Carcinoma Cells
por: Gao, Jing-Yan, et al.
Publicado: (2021) -
Inhibition of Hepatitis B Virus Replication by the Host Zinc Finger Antiviral Protein
por: Mao, Richeng, et al.
Publicado: (2013) -
The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells
por: Mandal, M, et al.
Publicado: (2005) -
Adenine inhibits growth of hepatocellular carcinoma cells via AMPK-mediated S phase arrest and apoptotic cascade
por: Su, Wei-Wen, et al.
Publicado: (2020)